Business Wire

Hirslanden Clinique La Colline Adopts Medacta’s Efficiency KneePack: the New Gold Standard in Resource Optimization and Knee Replacement Procedure Management

Share

Hirslanden Clinique La Colline, an internationally renowned clinic in Geneva and part of the first Swiss private clinic group Hirslanden, has optimized instrument management and implant stock for its total knee replacement (TKR) procedures by introducing Medacta’s Efficiency KneePack as the new standard in its practice. This advanced solution has helped Clinique La Colline to improve its supply chain and TKR procedure workflow, reducing the resources needed to manage procedures and enabling an even stronger focus on surgeons’ needs and patients’ wellbeing.

“I was already using Medacta’s MyKnee Patient-Specific cutting blocks, which have helped me achieve higher dependability with greater ease and comfort of use in every case,” said Dr. med. Jean-Philippe Corsat.

“The Single Use Instruments, delivered brand new and unworn every time, have been a great addition,” added Dr. med. Marc Saudan. “I didn’t have to change my technique at all; after a few cases, I was completely used to them.”

Delivered sterile and ready for use, the Efficiency KneePack is the ultimate solution to implant Medacta’s GMK® Primary or GMK® Sphere in a TKR procedure. The Efficiency KneePack includes femur and tibia implants, MyKnee® Patient-Matched cutting blocks and GMK® Efficiency single use instruments.

“Thanks to Medacta’s Efficiency KneePack, we have drastically streamlined our logistic workflow,” said André Joyeusaz, a Hirslanden Clinique La Colline logistics department representative. “Instrumentation sets and implants are delivered just a few days before surgery, limiting the stock here at the surgical unit. Everything we need is packaged together, minimizing any source of error and helping us more swiftly to manage the logistics. This is very important on busy days. Any problem related to lost or worn out instruments has been eliminated, including paperwork.”

“The first thing that I noticed was that these instruments are much lighter than the metal ones,” said Veronique Guerraz, a perioperative nurse at the clinic. “They are also very intuitive to assemble and require less thought process to set them up. I can quickly find the instruments needed at each surgical step thanks to their different colors and the organized layout. The packaged sets arrive already sterile and organized, so we do not have to check them before surgery; we can just open the blisters and start using the instruments.”

In order to facilitate the best possible outcomes, Medacta utilizes pre-operative computer-based surgical planning software to deliver exactly what is needed for the surgical procedure, including the Efficiency Instruments and implants. This minimizes inventory constraints and provides the necessary inventory to complete the specific surgical procedure.

“It is Medacta’s mission to address surgeon and hospital needs with advanced technologies that encourage patient wellbeing and healthcare system sustainability,” said Francesco Siccardi, Executive Vice President of Medacta International. “The Efficiency KneePack embodies this as it addresses pain points at every level. We believe it will become the gold standard for clinics and ambulatory surgical centers looking to optimize their resources.”

Clinique La Colline is the first center to use Medacta’s Efficiency KneePack, and other centers are now following suit.

About Medacta ® International

Medacta® International is a world leading manufacturer of orthopedic implants, neurosurgical systems, and instrumentation. Medacta’s revolutionary approach and responsible innovation have resulted in standard of care breakthroughs in hip replacement with the AMIS® system and total knee replacement with MyKnee® patient matched technology. Over the last 10 years, Medacta has grown dramatically by taking a holistic approach and placing value on all aspects of the care experience from design to training to sustainability. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 30 countries.

To learn more about Medacta International, please visit: https://www.medacta.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

for Medacta International
Jill Bongiorni, 516-729-2250
Jill@torchcomllc.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LTIMindtree, Eurobank and Fairfax Digital Services Collaborate to Build Digital Innovation Hub in Cyprus16.5.2025 10:00:00 EEST | Press release

LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, has announced the opening of its Digital Innovation Hub at the Research and Innovation Hub of CYENS Center of Excellence. The LTIMindtree Digital Innovation Hub will enable ideation, co-creation and implementation of Advanced Digital Solutions for Eurobank, Fairfax and other EU customers and aligns with the strategic vision of the Cyprus Government to strengthen Cyprus’ role as a regional tech and innovation hub, triggering unique cross-border opportunities for tech collaborations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515054331/en/ Srini Rao EVP & Chief Business Officer- Europe, LTIMindtree | Mr. Nikodemos Damianou, Deputy Minister of Research and Innovation, Govt of Cyprus | Mr. Fokion Karavias, Group CEO, EUROBANK Group | Mr. Sanjay Tugnait, President & CEO, Fairfax Digital along with other esteemed client execu

ROYC Acts as the Structuring and Financial Technology Partner for Riverside for European Wealth Access Fund16.5.2025 09:30:00 EEST | Press release

ROYC, the leading provider of complete private markets operating systems, announces the structuring of a new access fund for Private Wealth launched in collaboration with The Riverside Company. The Riverside Company is a global private equity firm focused on investing in growing businesses valued at up to $400 million. Since its founding in 1988, Riverside has made more than 1,000 investments and today has over $12 billion in assets under management. The firm's international private equity and structured capital portfolios include more than 140 companies. The Riverside’s proven investment strategy of acquiring and developing high-potential European SMEs in resilient, growth-oriented sectors, including technology and software, healthcare, advanced manufacturing and consumer products. “This fund represents a unique opportunity for wealth investors to access value creation generally reserved for institutional investors,” says Karsten Langer, Managing Partner at Riverside Europe and contin

Rimini Street Announces Upcoming 2025 Investor Conference Schedule15.5.2025 23:51:00 EEST | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that Michael L. Perica, chief financial officer, and Dean Pohl, vice president, treasurer and investor relations, will be presenting and meeting with investors one-on-one and in small group meetings at the following conferences: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515374696/en/ Rimini Street Announces Upcoming 2025 Investor Conference Schedule May 28, 2025: Craig-Hallum 22nd Annual Institutional Investor Conference, Minneapolis May 29, 2025: TD Cowen 53rd Annual TMT Conference, New York City Fireside Chat: 1:15 pm Eastern, webcast link June 24-26, 2025: Roth 15th Annual London Conference, London To schedule a meeting please contact your salesperson or Rimini Street Investor Relations at IR@rimin

Incyte Announces FDA Approval of Zynyz ® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States15.5.2025 21:30:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz® (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC). In addition, the FDA granted approval for Zynyz as a single agent for the treatment of adult patients with locally recurrent or with metastatic SCAC with disease progression on or intolerance to platinum-based chemotherapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250508024371/en/ Zynyz logo "The FDA approval of Zynyz marks a pivotal moment, bringing effective combination and monotherapy treatment options to patients with advanced anal cancer after decades of limited innovation," said Hervé Hoppenot,

DDC Announces Record 2024 Growth and Strategic Bitcoin Reserve Initiative in Shareholder Letter by Founder & CEO Norma Chu15.5.2025 21:23:00 EEST | Press release

DDC Enterprise Ltd. (NYSEAM: DDC), today released its 2024 full year results alongside a Shareholder Letter from Founder, Chairwoman, and CEO Norma Chu, underscoring the company’s positive financial performance and unveiling a pioneering Bitcoin accumulation strategy poised to redefine long-term value creation. To Our Valued Shareholders, 2024 was a year of transformative growth and strategic milestones for DDC. I am thrilled to share that we not only met our financial forecasts but exceeded expectations, delivering strong performance across key metrics while laying the groundwork for an even more exciting future. As we enter 2025, our momentum is accelerating, driven by disciplined execution and a bold new chapter in our corporate strategy. 2024 Financial & Operational Highlights Revenue Growth: USD 37.4 million, a 33% year-over-year increase, propelled by the strategic acquisition of U.S. brands and sustained resilience in our core China operations. Margin Expansion: Gross profit mar

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye